Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study.

For the composite outcome, the trend to a reduced mortality risk associated with ARBs as compared to ACEIs was still present, but did not reach statistical significance (MC-HR= 0.59; 95%CI 0.35–1.01) (Table 4 ).

also in 111,027 other papers

Interestingly, 80% of patients were prior users of ARBs, and the authors found quasi-significant results favoring continuation in older persons, obese patients, and in those clinically more severe, in line with our findings (see later).

also in 78 other papers